Journal article
Why don’t out-of-treatment individuals enter methadone treatment programmes?
The International journal of drug policy, Vol.21(1), pp.36-42
2010
DOI: 10.1016/j.drugpo.2008.07.004
PMCID: PMC2790538
PMID: 18805686
Abstract
Despite the proven effectiveness of methadone treatment, the majority of heroin-dependent individuals are out-of-treatment.
Twenty-six opioid-dependent adults who met the criteria for methadone maintenance who were neither seeking methadone treatment at the time of study enrollment, nor had participated in such treatment during the past 12 months, were recruited from the streets of Baltimore, Maryland through targeted sampling. Ethnographic interviews were conducted to ascertain participants’ attitudes toward methadone treatment and their reasons for not seeking treatment.
Barriers to treatment entry included: waiting lists, lack of money or health insurance, and requirements to possess a photo identification card. For some participants, beliefs about methadone such as real or rumored side effects, fear of withdrawal from methadone during an incarceration, or disinterest in adhering to the structure of treatment programmes kept them from applying. In addition, other participants were not willing to commit to indefinite “maintenance” but would have accepted shorter time-limited methadone treatment.
Barriers to treatment entry could be overcome by an infusion of public financial support to expand treatment access, which would reduce or eliminate waiting lists, waive treatment-related fees, and/or provide health insurance coverage for treatment. Treatment programmes could overcome some of the barriers by waiving their photo I.D. requirements, permitting time-limited treatment with the option to extend such treatment upon request, and working with corrections agencies to ensure continued methadone treatment upon incarceration.
Details
- Title: Subtitle
- Why don’t out-of-treatment individuals enter methadone treatment programmes?
- Creators
- James A PetersonRobert P SchwartzShannon Gwin MitchellHeather Schacht ReisingerSharon M KellyKevin E O’GradyBarry S BrownMichael H Agar
- Resource Type
- Journal article
- Publication Details
- The International journal of drug policy, Vol.21(1), pp.36-42
- DOI
- 10.1016/j.drugpo.2008.07.004
- PMID
- 18805686
- PMCID
- PMC2790538
- NLM abbreviation
- Int J Drug Policy
- ISSN
- 0955-3959
- eISSN
- 1873-4758
- Publisher
- Elsevier B.V
- Language
- English
- Date published
- 2010
- Academic Unit
- Center for Social Science Innovation; Internal Medicine
- Record Identifier
- 9984094405102771
Metrics
31 Record Views